Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01708421 · ClinicalTrials.gov registry record

Symptom Clusters in Children With Leukemia

A clinical trial, sponsored by Duke University.

Completed
Registry status
338
Enrollment target

NCT01708421: Completed study, sponsored by Duke University.

NCT01708421 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01708421 has completed, sponsored by Duke University.

COMPLETED
Registry status
338 participants
Enrollment target

Study Summary

The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2012-11
Est. Completion 2018-08-01
Duke University

1,725 total trials

What the finished NCT01708421 record still lists

NCT01708421 is an observational study that tracks outcomes without assigning an intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01708421 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01708421 about?

NCT01708421 is a clinical study titled "Symptom Clusters in Children With Leukemia". The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.

What is the current status of trial NCT01708421?

This trial is currently completed. The enrollment target is 338 participants. The study started on 2012-11. Estimated completion is 2018-08-01.

Who is sponsoring clinical trial NCT01708421?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03253263 · 338 participants · Phase 2

    A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

  • NCT05658731 · 338 participants · NA

    Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

  • NCT06022939 · 338 participants · Phase 3

    Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01708421, the US trial registry maintained by the National Library of Medicine. NCT01708421 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.